# BiancaMed

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/biancamed

- Industry: Medical Devices & Equipment
- Headquarters: Dublin, Ireland
- Website: www.biancamed.com
- Total disclosed funding: $12M
- Latest round: Series B (Jul 20, 2009)
- Investors on record: 4

## About

BiancaMed is an innovative company that specializes in providing advanced technology solutions tailored to healthcare needs, enhancing operational efficiency and user experience across various sectors.BiancaMed, founded in 2003 in Dublin, Ireland, focuses on healthcare technology solutions. In July 2011, the company was sold to ResMed. The latest funding round was a Series B round, raising EUR 6.00 mn, with investors including Enterprise Ireland, Seventure Partners, and ePlanet Capital, bringing the total amount raised to EUR 6.00 mn.BiancaMed's core product offerings include innovative solutions engineered to enhance operational efficiency in healthcare. Their flagship product, launched in 2021, emphasizes user-centric design and incorporates advanced technology. The company serves various sectors, including technology and finance, and markets its products in North America, Europe, and parts of Asia, catering to a broad clientele from small businesses to large corporations.The company's revenue model is based on a subscription structure with tiered pricing plans. This framework facilitates long-term relationships with clients through recurring revenue streams. BiancaMed engages in both direct-to-consumer sales and B2B partnerships, ensuring effective service to individual users and larger organizations. Each subscription plan provides access to the core product suite, with options for additional features available at set prices, promoting customer loyalty and scalable revenue growth through upselling opportunities.BiancaMed plans to expand its product offerings with new solutions targeting specific healthcare needs, with anticipated launches occurring in the upcoming year. The company is also targeting expansion into additional markets in Asia and Europe by 2024. The recent funding from the Series B round will support these initiatives, particularly the development of new products and market entry strategies.

## Funding rounds

- Series B, Jul 20, 2009, $8.4M — Seventure Partners, ePlanet Capital, Enterprise Ireland
- Series A, Dec 19, 2006, $3.3M — ePlanet Capital, ResMed Inc.

## Investors

- ePlanet Capital (https://capitalatlas.ai/funds/eplanet-capital) — Series A, Series B
- ResMed Inc. — Series A
- Seventure Partners (https://capitalatlas.ai/funds/seventure-partners) — Series B
- Enterprise Ireland (https://capitalatlas.ai/funds/enterprise-ireland) — Series B